| Bio Roundup: Cholesterol Check, J&J’s Opioid Hit, AbbVie’s Flop & More | Alex Lash | 08/30/19 | National |
| Merck Alzheimer Drug Is Latest To Fail In A Big Study | Alex Lash | 02/15/17 | National |
| After “Hubris” and Its HCV Collapse, Can Vertex Avoid Same Mistakes? | Ben Fidler | 10/18/16 | Boston |
| Merck Surges As Bristol’s Immunotherapy Drug Stumbles in Lung Cancer | Ben Fidler | 08/05/16 | Boston |
| In Race to Relief, Amgen Touts New But Incomplete Migraine Data | Alex Lash | 06/09/16 | San Francisco |
| With BioMarin Data, Gene Therapy Finally Shows Impact on Hemophilia A | Ben Fidler | 04/20/16 | San Francisco |
| East Coast Bio Roundup: PCSK9 Battle, NYU Startups, Blueprint & More | Ben Fidler | 03/17/16 | Boston |
| Amgen Bests Sanofi-Regeneron In PCSK9 Patent Case, Losers Vow Appeal | Alex Lash | 03/16/16 | New York |
| East Coast Biotech Roundup: Editas, Hep C, Akashi, Tarveda & More | Ben Fidler | 01/29/16 | Boston |
| At Duchenne Panel, Parents Plead With Experts, FDA Decision Looms | Ben Fidler | 11/24/15 | San Francisco |
| Gilead Climbs on More Good News for Cancer Drug From Seattle | Luke Timmerman | 10/10/13 | Seattle |
| ASCO Wrap-Up: Cancer News from the East, South, & Rockies | Luke Timmerman | 06/05/13 | National |
| Dendreon Shares Fall Again, as Provenge Sales Slump | Luke Timmerman | 05/09/13 | Seattle |
| Vertex Wins EU Approval for Cystic Fibrosis Drug | Luke Timmerman | 07/27/12 | Boston |
| Vertex Shares Drop on Mistake in Cystic Fibrosis Drug Data | Luke Timmerman | 05/29/12 | Boston |
| J&J Prostate Cancer Drug Hits Goal; Hurts Dendreon, Helps Medivation | Luke Timmerman | 03/08/12 | New York |
